Sep 22, 2025
Mallinckrodt Names Dr. Marek J. Honczarenko as EVP and Chief Scientific Officer
Sep 18, 2025
Mallinckrodt Announces Publication of Findings on Treatment Patterns and Outcomes in Patients with Two Types of Arthritis Treated with Acthar® Gel (repository corticotropin injection)
Aug 06, 2025
Mallinckrodt plc Reports Financial Results for Second Quarter 2025 and Provides Guidance
Aug 04, 2025
Mallinckrodt Names Leslie Donato to Board of Directors
Jul 17, 2025
Mallinckrodt Receives Necessary Ruling from Irish High Court to Combine with Endo, Inc.
Jun 18, 2025
Mallinckrodt Announces Publication of Real-World Insights on Patient Experience with Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect(TM) Injector
Jun 13, 2025
Mallinckrodt and Endo Shareholders Approve Combination to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Jun 09, 2025
Mallinckrodt, Endo Announce Planned Leadership Team for Merged Company
May 14, 2025
Mallinckrodt Presents Data on Real-World Outcomes with Acthar® Gel (repository corticotropin injection) at the International Congress on Systemic Lupus Erythematosus (LUPUS 2025)
May 13, 2025
Mallinckrodt and Endo Announce Significant Progress in Proposed Merger
May 06, 2025
Mallinckrodt plc Reports First Quarter 2025 Financial Results and Reaffirms Full-Year Guidance
Apr 23, 2025
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2025 Digestive Disease Week (DDW) Annual Meeting
Apr 10, 2025
Mallinckrodt plc to Report Earnings Results for First Quarter 2025
Mar 13, 2025
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Mar 13, 2025
Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides 2025 Guidance
Mar 10, 2025
Mallinckrodt plc Reschedules Release of Fourth Quarter and Fiscal Year 2024 Financial Results to Thursday, March 13, 2025
Dec 02, 2024
Mallinckrodt Completes Divestiture of Therakos® Business
Nov 18, 2024
Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting
Nov 14, 2024
Mallinckrodt to Present at Jefferies London Healthcare Conference
Nov 05, 2024
Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance